LENZ Therapeutics Statistics

Total Valuation

LENZ has a market cap or net worth of $618.77 million. The enterprise value is $403.24 million.

Market Cap	618.77M
Enterprise Value	403.24M

Important Dates

The last earnings date was Wednesday, November 6, 2024, before market open.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	Mar 22, 2024

Share Statistics

LENZ has 27.50 million shares outstanding. The number of shares has increased by 486.94% in one year.

Current Share Class	27.50M
Shares Outstanding	27.50M
Shares Change (YoY)	+486.94%
Shares Change (QoQ)	+6.11%
Owned by Insiders (%)	2.81%
Owned by Institutions (%)	41.25%
Float	12.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.87
P/TBV Ratio	2.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.63, with a Debt / Equity ratio of 0.01.

Current Ratio	28.63
Quick Ratio	28.16
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.90% and return on invested capital (ROIC) is -29.25%.

Return on Equity (ROE)	-41.90%
Return on Assets (ROA)	-27.03%
Return on Capital (ROIC)	-29.25%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-179,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.62% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+15.62%
50-Day Moving Average	31.59
200-Day Moving Average	23.52
Relative Strength Index (RSI)	27.83
Average Volume (20 Days)	197,646

Short Selling Information

The latest short interest is 2.53 million, so 9.18% of the outstanding shares have been sold short.

Short Interest	2.53M
Short Previous Month	2.26M
Short % of Shares Out	9.18%
Short % of Float	20.18%
Short Ratio (days to cover)	17.72

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-68.37M
Pretax Income	-117.37M
Net Income	-60.81M
EBITDA	-68.34M
EBIT	-68.37M
Earnings Per Share (EPS)	-$2.69

Full Income Statement

Balance Sheet

The company has $217.11 million in cash and $1.58 million in debt, giving a net cash position of $215.53 million or $7.84 per share.

Cash & Cash Equivalents	217.11M
Total Debt	1.58M
Net Cash	215.53M
Net Cash Per Share	$7.84
Equity (Book Value)	215.28M
Book Value Per Share	7.83
Working Capital	212.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$71.28 million and capital expenditures -$319,000, giving a free cash flow of -$71.60 million.

Operating Cash Flow	-71.28M
Capital Expenditures	-319,000
Free Cash Flow	-71.60M
FCF Per Share	-$2.60

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of $7.21, which amounts to a dividend yield of 32.04%.

Dividend Per Share	$7.21
Dividend Yield	32.04%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-486.94%
Shareholder Yield	-454.90%
Earnings Yield	-9.83%
FCF Yield	-11.57%

Dividend Details

Analyst Forecast

The average price target for LENZ is $35.40, which is 57.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$35.40
Price Target Difference	57.33%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1